Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Bever

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 6, 1997
Dexfenfluramine hydrochloride: an anorexigenic agentK A Bever, P J Perry
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 2, 1998
Olanzapine: a serotonin-dopamine-receptor antagonist for antipsychotic therapyK A Bever, P J Perry
Pharmacotherapy|December 17, 1997
N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopeniaM D Combs, P J Perry, K A Bever
Pharmacotherapy|August 24, 1999
Testosterone and andropause: the feasibility of testosterone replacement therapy in elderly menB C Lund, K A Bever-Stille, P J Perry
Biological Psychiatry|November 3, 1998
Relationship between patient variables and plasma clozapine concentrations: a dosing nomogramP J Perry, K A Bever, S Arndt, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|September 6, 2001
Bioavailable testosterone as a correlate of cognition, psychological status, quality of life, and sexual function in aging males: implications for testosterone replacement therapyP J Perry, B C Lund, S Arndt, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|January 17, 2002
Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adultsS Kuperman, P J Perry, G R Gaffney, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 6, 1997
Dexfenfluramine hydrochloride: an anorexigenic agentK A Bever, P J Perry
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 2, 1998
Olanzapine: a serotonin-dopamine-receptor antagonist for antipsychotic therapyK A Bever, P J Perry
Pharmacotherapy|December 17, 1997
N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopeniaM D Combs, P J Perry, K A Bever
Pharmacotherapy|August 24, 1999
Testosterone and andropause: the feasibility of testosterone replacement therapy in elderly menB C Lund, K A Bever-Stille, P J Perry
Biological Psychiatry|November 3, 1998
Relationship between patient variables and plasma clozapine concentrations: a dosing nomogramP J Perry, K A Bever, S Arndt, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|September 6, 2001
Bioavailable testosterone as a correlate of cognition, psychological status, quality of life, and sexual function in aging males: implications for testosterone replacement therapyP J Perry, B C Lund, S Arndt, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|January 17, 2002
Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adultsS Kuperman, P J Perry, G R Gaffney, et al.
Pageof 1